awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38693748-149E517D-8982-40FC-830C-3ADDAA9328E4
Q38693748-149E517D-8982-40FC-830C-3ADDAA9328E4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38693748-149E517D-8982-40FC-830C-3ADDAA9328E4
Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: a systematic review.
P2860
Q38693748-149E517D-8982-40FC-830C-3ADDAA9328E4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38693748-149E517D-8982-40FC-830C-3ADDAA9328E4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a085f8c976c2acd1fb663cc5af8d0908f1cc31d6
P2860
An open-label single-arm pilot phase II study (PX-171-003-A0) of low-dose, single-agent carfilzomib in patients with relapsed and refractory multiple myeloma.